SAN FRANCISCO (AP) -- Zynga is reporting a small profit in the first three months of the year, as the online game company reduced expenses. But a revenue decline and a lower-than-expected second-quarter forecast are sending its stock tumbling.

Zynga Inc. said Wednesday that it earned $4.1 million, or a breakeven per share. A year earlier, it lost $85.4 million, or 12 cents per share. Adjusted earnings were 1 cent per share, compared with expectations for a loss of 3 cents.

Revenue fell 18 percent to $263.6 million.

FactSet says analyst had expected revenue of $264.5 million.

For the current quarter, Zynga is forecasting an adjusted loss of 3 cents to 4 cents per share on revenue of $225 million to $235 million. Analysts were expecting a smaller loss and higher revenue.

The bank originally reported earnings attributable to common shareholders of $958 million, or 49 cents per share, but revised that to $936 million, or 48 cents per share, according to Morgan Stanley's 10-Q filing with the U.S. Securities and Exchange Commission.

Since its earnings day, Morgan Stanley has settled litigation with Abu Dhabi Commercial Bank and King County, Washington, over structured investment vehicles issued during the financial crisis.

(Reporting By Lauren Tara LaCapra; Editing by Steve Orlofsky)

He didn't deserve any blame for fans leaving early, either, though hundreds found their way to the exit even before the 12th round began.

If they were spending $1,000 and up for tickets to a brawl, they should have known better. Mayweather built a career on not getting hit, and there was no reason to think he was going to make the same mistakes as last year against Miguel Cotto against a fighter whose only hope of winning was to rough him up.

Instead of booing, they should have been applauding. Instead of leaving, they should have been on their feet cheering.

On the canvas where he does his best work, Mayweather painted a boxing masterpiece only he could produce.

"Everyone was saying at the age of 36 I don't have it no more," Mayweather said. "All I want to do is give fans exciting fights."

This one wasn't as much exciting as it was brilliant. Mayweather used defensive skills built up over a lifetime to take apart a very good fighter Saturday night and do it in such lopsided fashion that ringside judges seemed to be searching for a round to give to Guerrero.

He hit Guerrero with right hand leads all night and might have knocked him out had he not hurt his hand in the eighth round. When Guerrero tried to land big shots of his own, Mayweather was either smothering him on the ropes or had danced out of harm's way.

It was a $32 million display of all that's right about the sweet science. And if it didn't satisfy all the fans at the MGM Grand or those who paid $69.95 for the pay-per-view, it kept Mayweather undefeated in 44 fights in what is becoming a remarkable boxing career.

"I showed the world I can still box," Mayweather said. "I showed my defense is still there. I'm still fast."

Most importantly, perhaps, it showed Mayweather himself that he still has it. After spending two months in jail and a year out of the ring, he returned with a performance that was vintage Mayweather.

His father was back in the corner and was put to good use. Both Floyd Sr. and Floyd Jr. thought the boxer got hit too much when he went toe-to-toe with Cotto last May and were determined to focus on defense against Guerrero, who tried his best for 12 rounds to turn the fight into a brawl, to no avail.

The plan was to hit and not get hit. It worked to perfection, with Guerrero landing only 19 percent of his punches to 41 percent for Mayweather.

"The less you get hit, the longer you last in boxing," Mayweather said.

Mayweather has followed that creed so well that he has lasted 17 years in the sport, and he looks no worse for the wear. He's managed to build a boxing empire on pay-per-view sales despite having a style that is less than crowd pleasing, and his $32 million payday for Guerrero shows he remains a huge attraction.

He wants to fight again in September, which would be the first time since 2007 he fought twice in a calendar year. That could be delayed by his injured right hand, though Mayweather insisted after the fight he would be ready to go.

The question now becomes who Mayweather will face. Upcoming Mexican star Canelo Alvarez would be the most attractive fight, but the short lead time to September virtually ensures that bout won't happen until at least next May, at best.

Mayweather is in the unique position where he can handpick his opponents, and he's been criticized for trying to find fighters he knows he can beat. Alvarez would be a risky fight, one Mayweather might want to save until late in the remaining five fights he has under a deal with Showtime that he says will be the last of his career.

"He's a young guy," Mayweather said of Alvarez. "Floyd Mayweather isn't going to duck anybody. My job is to go out there, rack up victories and be the best Floyd Mayweather I can be."

Whether that is good enough to make Mayweather among the all-time greats was a topic of questioning at the post-fight news conference. Mayweather may be a dominating fighter, but he hasn't had a rivalry to get fight fans excited and he came up with excuse after excuse not to fight Manny Pacquiao when Pacquiao was still in his prime.

He also hasn't fought regularly enough to press a claim for greatness, something that could change if he goes through on plans to fight every six months or so under the Showtime deal.

"I just do what I do," Mayweather said. "I've given this sport my whole life."

The Save the…Humans™ e-book was written to explain why we need a critical mass of souls who understand that we are all One in spirit to peacefully manifest a global transformation in consciousness.

The life coaching and Self-mastery products are available on Holistic Learning Center’s website between midnight on April 30th through midnight May 2nd to download at no cost.

The self help products are in exchange for forwarding the Save the…Humans™ e-book to as many people as possible and “liking” Holistic Learning Center’s Facebook Fan Page.Stay tuned for this month’s product, titled The Conscious Creation Process.

Life coaches, healers, self-help enthusiasts and members of holistic organizations are welcome to freely distribute Holistic Learning Center’s clinically proven self-mastery products via its Abundance Exchange Inner-net of One program.

These empowering life coaching and Self-mastery products, valued at up to thirty five dollars, can be used to help independent life coaches quickly build a large base of potential life coaching prospects when sent to their entire email list and Facebook friends who in turn forward the self-mastery products to all of their holistic friends each and every month.

The products are also useful for educating friends and family members on how to help improve their adult life skills techniques and live a more empowered life in the same way Holistic Learning Center educates its students toand their clients to heal.

Sabrina RoseHolistic Learning Center888-452-0878 3

Biofuels are renewable sources of energy created using living organisms such as plants. The most common biofuel used in vehicles today is ethanol, more commonly known as drinking alcohol.

"Global demand for energy is rising and a fuel that is independent of both global oil price fluctuations and political instability is an increasingly attractive prospect," said researcher John Love, a synthetic biologist at the University of Exeter in England.

However, ethanol is not fully compatible with modern engines. As such, it requires blending withproducts, which means it can only meet a small fraction of the world's transportation fuel demand.

In contrast, "we are using synthetic biology to make not an alternative biofuel, but exact replicas of the fossil fuels that we use in engines today," Love told TechNewsDaily. "We can now make biofuels that function exactly like fossil fuels and require absolutely no modifications to existing engine technology." [See also: ]

The researchers devoted a decade to finding a way to use microbes to manufacture the kind of fuel molecules found in petroleum, known as alkanes. Nine of those years were spent looking at existing microbes for candidates "with very little progress," Love recalled. At one point, their industrial backers "even pulled the plug on our funding, as the research was going so slowly."

Love and his colleagues then decided to employ a synthetic biology approach to the problem they would take bits and pieces of a chemical pathway to make these fuel molecules from many different organisms and combine them into a single microbe in a way that did not exist before .

"That was the breakthrough," Love said. "It only took six months from that decision to get the first indication that we could produce and customize bio-alkanes."

Thethe researchers used was E. coli, a bacterium that normally lives in the human gut and is commonly used for lab research. E. coli naturally converts sugars into fat to build its cell membrane. The researchers altered this natural oil production system to make the kind of alkanes normally found in diesel orfuel. This required borrowing genes from a wide variety of organisms, including a bioluminescent bacterium, from the camphor tree, and from cyanobacteria, more commonly known as blue-green algae.

The microbes used to commercially manufacture ethanol currently do so by consuming sugar from crops such as corn and sugarcane. The bacteria Love and his colleagues employed to create alkanes also use sugar, but that sugar could come from other sources, including waste products.

"There is no reason that we couldn't use their potential to metabolize waste organic compounds such as waste plant biomass, or even animal waste or sewerage," Love said.

The researchers, who were supported by the oil company Shell,caution their technology still faces many challenges before it is ready for market, such as high enough yields for commercialization. Over the course of the next three years, "our aim is to increase yields hundredfold," Love said.

The scientists detailed their findings online April 22 in the journal Proceedings of the National Academy of Sciences.

This story was provided by , a sister site to LiveScience.

* American closes with a nine-birdie 64

* D.A. Points finishes second after 65 (Adds detail, quotes)

April 28 (Reuters) - American Billy Horschel charged ahead with six consecutive birdies, then held his nerve down the stretch to win his maiden PGA Tour title by one shot at the Zurich Classic of New Orleans in Avondale, Louisiana on Sunday.

Two strokes off the pace going into a weather-disrupted final round, Horschel took advantage of rain-softened conditions and preferred lies at the TPC Louisiana as he sealed his long-awaited breakthrough victory with an eight-under-par 64.

The slim 26-year-old, who had recorded top-10s in his three previous starts on the U.S. circuit, stunningly drained a 26-foot birdie putt at the par-five last to post a 20-under total of 268.

Horschel repeatedly pumped his right fist in delight after his ball disappeared into the cup for his ninth birdie of the day, then removed his cap to acknowledge loud cheers from the gallery packed around the 18th green.

"Oh man, it's something I have worked so hard for and there are so many people I need to thank. And they all know who they are," an emotional Horschel told Golf Channel after coping with two weather delays during the final round.

"And for that putt to go in ... I hadn't made a long one all week and I said, 'I am due for a long one, I am due for a long one. Just commit to it.'

"It came off the putter so good and I am so happy it went in. This is unbelievable right now."

Fellow American D.A. Points, playing with Horschel, had been tied for the lead with three holes remaining but settled for second place after closing with a seven-birdie 65.

Overnight leader and 2009 U.S. Open champion Lucas Glover, bidding for his fourth PGA Tour victory, fell back with an early bogey on the way to a 71 and a tie for fourth at 15 under.

Glover began the day two strokes in front and he parred the first five holes before play was suspended for about three hours as the first wave of thunderstorms rolled into the area.

At that point, his lead had shrunk to just.

THREE-WAY TIE

Soon after play resumed, Points and Horschel briefly moved into a three-way tie at the top as they each birdied the par-five seventh before Jimmy Walker sank a 26-foot eagle putt at the same hole to edge a stroke in front.

Glover slid back with a bogey at the seventh after overshooting the green and hitting a poor chip coming back.

Former Walker Cup amateur Horschel also birdied the eighth and ninth to move one ahead at 16 under before being joined by Walker, who rolled in a 10-footer to birdie the par-four eighth.

While Walker stumbled with a double-bogey at the par-three ninth, where his bump-and-run from below the green failed to crest the slope and rolled back to his feet, red-hot Horschel kept charging forward.

He sank a 14-footer to birdie the 10th and a six-footer at the par-five 11th to get to 18 under, two ahead of Points.

Both players picked up a shot at the par-four 12th, Horschel sinking a 15-footer there to tie the PGA Tour record this season of six consecutive birdies.

Horschel, speeding up in his play, bogeyed the 15th after finding the right rough off the tee and missing the green with his approach.

That dropped him into a tie with Points, who had recorded his sixth birdie of the day at the 13th.

Horschel rebounded with a birdie at the par-four 16th after hitting an exquisite approach to four feet to regain a one-stroke cushion.

Play was again suspended, for just under an hour, due to the threat of lightning shortly after Horschel drove into the left rough off the 18th tee.

On resumption, he wisely laid up in two, then struck a wedge approach to 26 feet short of the hole before sinking the birdie putt to clinch an emotional victory.

British world number four Justin Rose, the highest-ranked player in the field, closed with a 69 to tie for 15th at 12 under, level with 2012 Masters champion Bubba Watson (66) and four-times major winner Ernie Els (68).

China's 14-year-old Guan Tianlang, after making his second consecutive cut on the PGA Tour, signed off with a two-over 74 to finish at four-over 292, stone last in the 71-strong field. (Reporting by Mark Lamport-Stokes in Los Angeles; Editing by Gene Cherry)

- - - -

SOCCER

English Premier League

MANCHESTER - Manchester United reclaimed their Premier League crown in style on Monday as Robin van Persie's hat-trick inspired a 3-0 win over Aston Villa that gave them an unassailable 16-point lead over Manchester City and erased the pain of last season. (SOCCER-ENGLAND/, (PIX), moved, by Sonia Oxley, 900 words)

- -

Champions League semi-final, first leg

Bayern Munich v Barcelona (1845)

Bayern Munich face Barcelona in the first of two titanic Champions League semi-final first legs with the German hosts seeking an emphatic advantage over the 2011 European championsto take to the Nou Camp next week. (SOCCER-CHAMPIONS/ (PIX), expect by 2030 GMT/4.30 PM ET, by Brian Homewood, 600 words)

- - - -

NBA

Bulls beat Nets to tie series at 1-1

Luol Deng had 15 points and 10 rebounds and Carlos Boozer added 13 points and 12 rebounds as Chicago beat hosts Brooklyn to even up the Eastern Conference first-round series. (NBA-HIGHLIGHTS/, moved, by Sports Direct, 600 words)

- - - -

NHL

Playoff chase down to final week

Daniel Sedin recorded a goal and an assist to become the second-leading scorer in franchise history as hosts Vancouver clinched their fifth consecutive Northwest Division title. (NHL-HIGHLIGHTS/, moved, by SportsDirect, 600 words)

- - - -

BASEBALL

Napoli delivers grand slam as Boston beat Oakland

Mike Napoli delivered a grand slam to spark a five-run fifth inning and Will Middlebrooks added a three-run homer as hosts Boston downed Oakland. (BASEBALL-HIGHLIGHTS/, moved, by SportsDirect, 600 words)

- - - -

TENNIS

ATP Tour:

Barcelona Open (to 28)

Berdych begins Barcelona bid against Davydenko BARCELONA - World number six Tomas Berdych begins his Barcelona Open campaign with a second-round clash against former number three Nikolay Davydenko of Russia. (TENNIS-MEN/BARCELONA, expect by 1700 GMT/1 PM ET, 300 words)

- -

Romania Open, Bucharest (to 28)

WTA Tour:

Stuttgart Grand Prix (to 28)

Morocco Grand Prix (to 28)

Copy on merit

- - - -

SNOOKER

World championship, Sheffield, England (to May 6)

Copy on merit

- - - -

CYCLING

Tour of Romandie, Switzerland (to April 28)

Copy on merit (Duty editor: Peter Rutherford)

Still, she spends most of her time on her cellphone checking email, Facebook, Pinterest and watching Netflix. At bedtime, she stays on her phone or laptop until after I have gone to bed. When she comes to bed, she ignores me and goes straight to sleep, even if I have been lying there awake in the dark waiting for her.

Has she fallen in love with her cellphone? Even if we don't have sex all the time, I would just like to be able to talk to her or hold her for a minute before we go to sleep. Any suggestions other than throwing her phone out the window? -- ABANDONED HUSBAND IN UTAH

DEAR ABANDONED: You say your wife has responded and things are hopeful. That means she is at least receptive to working on your marital relationship.

The problems that cellphones cause in relationships is something I am hearing about with increasing frequency. People have become so dependent upon their digital companions that in some cases it's impossible to turn them off because people have become literally addicted.

In cases like this, a licensed therapist should be consulted. Of course, like any addiction the sufferer must be willing to admit there is a problem and want to do something about it. I wish there was a 12-step program to which I could refer you, but I was unable to locate one. In the future I'm willing to bet that they'll sprout up like mushrooms.

DEAR ABBY: Six months ago, I realized I had a drinking problem and decided to go through a chemical dependence program as an outpatient. I'm sober now and attend meetings a few times a week. My problem is someone I was barely acquainted with was also in the same program. I didn't regard it as a problem at first, but now I'm concerned.

At a meeting a few months ago, I mentioned to the group that I also attend a meeting in another town closer to my home. Next thing I know, this man is attending the same meeting. He always makes a point of telling me about what's going on with the people we went through treatment with.

I am active in service work and plan to attend a regional meeting at a resort over a weekend. Guess who has suddenly decided to do the same?

I'm nervous about being around this man. I don't want to compromise his sobriety, but I can't stand seeing him at every meeting and event I attend. My husband is also bothered by it, and I'm considering not attending any meetings at all because he's creeping me out. How should I handle this? -- SOBER AND CREEPED OUT

DEAR CREEPED OUT: If there is a group moderator or contact, discuss this with that person. Because you want less contact with your "admirer," look around for another group. Even if you will have to travel a bit farther, it will be worth the effort.

If you do happen to run into him in the future and he tries to engage you in conversation about other patients from your program, cut the conversation short by telling him you are not interested in hearing about them. One of the hallmarks of 12-step programs is anonymity -- and it should be respected.

Dear Abby is written by Abigail Van Buren, also known as Jeanne Phillips, and was founded by her mother, Pauline Phillips. Write Dear Abby ator P.O. Box 69440, Los Angeles, CA 90069.

What teens need to know about sex, drugs, AIDS and getting along with peers and parents is in "What Every Teen Should Know." Send your name and mailing address, plus check or money order for $7 (U.S. funds) to: Dear Abby, Teen Booklet, P.O. Box 447, Mount Morris, IL 61054-0447. (Shipping and handling are included in the price.)

People have their own version of this hormone, and the new work suggests that giving diabetics more might one day help them avoid insulin shots.

That would give them better control of their blood sugar levels, said Harvard University researcher Douglas Melton, senior author of a report published Thursday by the journal Cell.

Experts unconnected with the work cautioned that other substances have shown similar effects on mouse cells but failed to work on human ones. Melton said this hormone stands out because its effect is unusually potent and confined to just the cells that make insulin.

An estimated 371 million people worldwide have diabetes, in which insulin fails to control blood sugar levels. High blood sugar can lead to heart disease, stroke and damage to kidneys, eyes and the nervous system. At least 90 percent of diabetes is "Type 2," and some of those patients have to inject insulin. Melton said the newly identified hormone might someday enable them to stop insulin injections and help other diabetic patients avoid them.

As for its possible use to treat Type 1 diabetes, Melton called that a "long shot" because of differences in the biology of that disease.

Insulin is produced by beta cells in the pancreas.

Melton and co-authors identified a hormone they dubbed betatrophin (BAY-tuh-TROH-fin) in mice. When they made the liver in mice secrete more of it by inserting extra copies of the gene, the size of the beta cell population tripled in comparison to untreated mice. Tests indicated the new cells worked normally.

Melton said it's not known how the hormone works. Now the researchers want to create an injectable form that they can test on diabetic mice, he said. If all goes well, tests in people could follow fairly quickly.

Dr. Peter Butler, a diabetes researcher at the University of California, Los Angeles, who had no role in the new work, cautioned in an emailthat no evidence has been presented yet to show that the hormone will make human beta cells proliferate.

But Philip diIorio, of the University of Massachusetts Medical School in Worcester, said he found the work to be "quite promising" because it offers new leads for research, and that it might someday help in building supplies of human beta cells in a lab for transplant into patients.

___

Online:

Cell: http://www.cell.com/

International Diabetes Federation: http://www.idf.org

___

Malcolm Ritter can be followed at http://www.twitter.com/malcolmritter

NEW YORK (AP) -- Thermo Fisher Scientific Inc. is reportedly nearing a deal to buy Life Technologies Corp., a maker of genetic testing equipment, for almost $12 billion.

Thermo Fisher's bid for Life Technologies topped $70 a share, beating out bids from other suitors, including the Blackstone Group, the Carlyle Group and other private equity firms, according to published reports. Life Technologies' stock closed Friday at $68.

Life Technologies, based in Carlsbad, Calif., said in January that it had hired Deutsche Bank and the boutique bank Moelis & Co. to help with its strategic review. That's usually a sign a company is considering putting itself up for sale. Since that announcement, the company's stock has climbed 24 percent.

Calls to Life Technologies and Thermo Fisher, based in Waltham, Mass., were not immediately returned.